Author

J. Chiou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Evolutionary Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Assay:ChIP-seq· 1

Frequent Co-Authors

A. R. Harrington· 1 shared B. R. Cross· 1 shared C. M. Metallo· 1 shared C.-J. Yang· 1 shared F. Liu· 1 shared F. Mulas· 1 shared H. S. Kwan· 1 shared J. Chang· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. R. Harrington

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The Phylotranscriptomic Hourglass Pattern in Fungi: An Updated Model

Y. Xie, H. S. Kwan, P. L. Chan, W. Wu, J. Chiou, J. Chang

The paper updates the developmental hourglass model in fungi, identifying germinating spores as the conserved 'waist' and highlighting transcriptomic conservation across fungal phyla.

bioRxiv · Jul 14, 2022 · PreprintEvolutionary Biology

Nutrient regulation of the islet epigenome controls adaptive insulin secretion

M. Wortham, F. Liu, J. Y. Fleischman, M. Wallace, F. Mulas, N. K. Vinckier, A. R. Harrington, B. R. Cross, J. Chiou, N. A. Patel, Y. Sui, U. S. Jhala, O. S. Shirihai, M. O. Huising, K. J. Gaulton, , M. Sander

This study shows that nutrient-stimulated histone acetylation regulates the islet epigenome to control adaptive insulin secretion, with Lsd1 playing a key role in this process.

bioRxiv · Aug 21, 2019Physiology

TAO Kinase 3 Overexpression Is a Poor Prognosis Marker for Lung Adenocarcinoma and Predicts Paclitaxel Resistance

P. M.-H. Chang, T.-C. Lai, Y.-C. Yang, Y.-C. Chang, J. Chiou, M.-S. Huang, C.-J. Yang, M. Hsiao

This study shows TAOK3 overexpression correlates with poor prognosis and paclitaxel resistance in lung adenocarcinoma, suggesting it as a therapeutic target.

bioRxiv · Apr 29, 2019 · PreprintCancer Biology